Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome

Neuromuscular Disorders

Volumn 19, Issue 10, 2009, Pages 709-710

  Sutter, R ^a   Mengiardi, B ^b   Lyrer, P ^a   Czaplinski, A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b IMAMED Radiological Institute of Basel   (Switzerland)

Author keywords

Cortical blindness; Guillain Barr syndrome; Hypertension; Intravenous immunoglobulin therapy; Posterior reversible encephalopathy syndrome

Indexed keywords

ALBUMIN; AMLODIPINE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN; METOPROLOL; RAMIPRIL;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; QUADRIPLEGIA; TACHYPNEA;

BRAIN; BRAIN DISEASES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; GUILLAIN-BARRE SYNDROME; HEADACHE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 70349249337     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.06.370     Document Type: Article

References (13)

1. Hinchey J., Chaves C., Appignani B., et al. A posterior reversible leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
2. Lichtenfield P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 326 (1971) 1130-1136
3. Delande S., De Sèze J., Hurtevent J.P., Stojkovic T., Hurtevent J.F., and Vermersch P. Cortical blindness associated with Guillain-Barré syndrome : a complication of dysautonomia?. Rev Neurol (Paris) 161 4 (2005) 465-467
4. Doss-Esper C.E., Singhal A.B., Smith M.S., and Henderson G.V. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barré syndrome. J Neuroimaging 15 2 (2005) 188-192
5. Kiochihara R., Hamano S., Yamashita S., and Tanaka M. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome. Pediatr Neurol 39 2 (2008) 123-125
6. Elahi A., Kelkar P., and St Louis E.K. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care 1 4 (2004) 465-468
7. Van Diest D., Van Goethem J.W., Vercruyssen A., Jadoul C., and Cras P. PRES and Guillain-Barré syndrome in a single patient: coincidence or causative relation?. Clin Neurol Neurosurg 109 1 (2007) 58-62
8. Lamy C., Oppenheim C., Meder J.F., and Mas J.L. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14 (2004) 89-96
9. Voltz R., Rosen F.V., Yoursy T., Beck J., and Hohlfeld R. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology 46 (1996) 250-251
10. Mathy I., Gille M., Van Raemdonck F., Delbecq J., and Depré A. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 98 (1998) 347-351
11. Magaña S.M., Matiello M., Pittock S.J., et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72 8 (2009) 712-717
12. Tateishi Y., Iguchi Y., Kimura K., Aoki J., Uemura J., and Shibazaki K. A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome. J Neurol Sci 271 1-2 (2008) 203-206
13. Leroux G., Sellam J., Costedoat-Chalumeau N., et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 17 2 (2008) 139-147